Lab-grown salmon on sale in the U.S.: First seafood to earn FDA approval

Credit: Wildtype
Credit: Wildtype

The Coho salmon, pinkish orange and streaked with lines of white fat, wasn’t wild-caught in Alaska or farmed in Chile. It comes from cells grown in tanks at a former microbrewery in San Francisco, and in late May it became the first cell-cultured seafood to receive safety approval from the U.S. Food and Drug Administration.

At least two lab-grown chicken products have previously gotten the FDA’s green light. But the okay for the salmon, made by California-based Wildtype, marks a significant milestone for the alternative protein industry, which has been working to produce substitutes for traditional meat and fish…

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

While alternative protein can be made from plants or fermentation, cultivated seafood primarily comes from animal cells. Cells are isolated from specific species, providing the material needed to establish continually usable cell lines.

“We’re addressing food security,” said Lou Cooperhouse, founder and president of BlueNalu, a San Diego-based company making cell-cultured bluefin tuna. “Wildtype’s approval was really great for the whole industry.”

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.